At this year’s ESCRS, one of the most memorable event was #iNovationDay, a first-of-its-kind event marking a new annual tradition in the society’s community.

VSY Biotechnology holds The Gold Sponsor of this programme which featured a balanced mix of doctors and global executives from established and emerging public and private companies.

Efe Can, MD, our Global Innovation and Medical Affairs Director shared how we approach for the future of innovation in ophthalmology at this remarkable session. He commented on what to expect in the Ophthalmic Industry for the next 5 years at the round table with other industry players.

He also highlighted the importance of being an agile company to adapt to the changing macro-economic environment while keeping sustainable growth. He added that the key to ensuring a sustainable growth in the era of crisis is being a self-sufficient company as we’ve took several crucial steps to that end to become a self-sufficient company from the aspects of supply safety and energy sustainability to packaging. Innovation is one of the key drivers of growth for VSY Biotechnology.

We are more than happy to be participated and contributed to this remarkable session as well as accompanying this new affair that was held for the first time in ophthalmology culture.